Scientific Library
Anti-Tag antibodies you can rely on: a focus on GFP and RFP
My colleague Ana introduced in a previous post (3 years ago already!) a selection of the most popular anti-tag antibodies among the research community. I must say that they remain extremely
Tropical & vector-borne disease antibodies : find your match for Rapid Assays!
Tropical and vector-borne diseases account for more than 17% of all infectious diseases, causing more than 1 million deaths annually. Recognizing infected patients early in their clinical course is critical
Immunoassay development: reliable sources of quality reagents
We understand how crucial it is to have access to sustainable, quality sources of reagents when developing and/or producing the same immunoassays over long periods of times. Over the years,
Empowering Immunology Research with Precision Products and Services
Enhance Your Therapeutic mRNA Research Projects with Modified NTPs
How Modified NTPs are Revolutionising mRNA Vaccine Technology
In recent years, the spotlight on mRNA (messenger RNA) technology has intensified, largely due to its pivotal role
Optimising mRNA for Therapeutics: The Synergy of CleanCap Technology and Minimal UTRs
mRNA and UTRs: Unlocking New Frontiers in Therapeutic Innovation
Over the past five years, there has been an explosive surge in scientific interest surrounding messenger RNA (mRNA),
Revolutionising mRNA Production: When Simplicity Meets Efficiency
mRNA-Based Therapeutics: Pioneering the Future of Medicine
Over the past few years, mRNA-based therapeutics have emerged as a promising approach to treat various diseases, including
Unlocking the Next Frontier in Immuno-Oncology: Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
In the ever-evolving field of immuno-oncology, the race to develop the most effective cell-based therapies has never been
[Tebubio Newsletter - Edition 1] Everything You Need, in One Place
Stay ahead in your research with your monthly Tebubio newsletter—your go-to source for innovative reagents, expert services, and insightful articles. Curated to bring you the most relevant products, services
Bispecific Antibodies: A Revolution in Cancer Treatment
In this blog, we will delve into how BITE antibodies, are transforming cancer treatment strategies, with a special focus on the tools developed by our partner, BPS Biosciences, to help you develop and